10,160 Shares in Astera Labs, Inc. (NASDAQ:ALAB) Acquired by Elemental Capital Partners LLC

Elemental Capital Partners LLC acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 10,160 shares of the company’s stock, valued at approximately $1,346,000. Astera Labs makes up 1.3% of Elemental Capital Partners LLC’s portfolio, making the stock its 6th largest holding.

Other large investors also recently made changes to their positions in the company. Hollencrest Capital Management acquired a new stake in shares of Astera Labs in the third quarter worth $26,000. Geneos Wealth Management Inc. acquired a new stake in shares of Astera Labs in the fourth quarter worth $36,000. ORG Wealth Partners LLC acquired a new stake in shares of Astera Labs in the fourth quarter worth $42,000. US Bancorp DE acquired a new stake in shares of Astera Labs in the third quarter worth $46,000. Finally, First Horizon Advisors Inc. acquired a new stake in shares of Astera Labs in the third quarter worth $49,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Buying and Selling at Astera Labs

In other news, CFO Michael Truett Tate sold 16,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $117.84, for a total value of $1,885,440.00. Following the transaction, the chief financial officer now owns 1,412,888 shares of the company’s stock, valued at $166,494,721.92. This trade represents a 1.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Manuel Alba sold 11,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $117.50, for a total transaction of $1,292,500.00. Following the completion of the transaction, the director now directly owns 456,863 shares in the company, valued at approximately $53,681,402.50. This represents a 2.35 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 858,452 shares of company stock worth $87,564,136 over the last ninety days.

Analyst Upgrades and Downgrades

ALAB has been the subject of a number of recent analyst reports. Roth Mkm raised their price target on shares of Astera Labs from $80.00 to $105.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Needham & Company LLC reiterated a “buy” rating and issued a $65.00 price objective on shares of Astera Labs in a research report on Wednesday, October 9th. Barclays lifted their price objective on shares of Astera Labs from $87.00 to $135.00 and gave the company an “overweight” rating in a research report on Friday, January 17th. Stifel Nicolaus lifted their price objective on shares of Astera Labs from $100.00 to $150.00 and gave the company a “buy” rating in a research report on Monday, January 6th. Finally, Morgan Stanley lowered their price objective on shares of Astera Labs from $142.00 to $114.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 28th. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $107.42.

Astera Labs Stock Performance

ALAB stock opened at $106.57 on Thursday. The firm has a 50 day simple moving average of $122.20 and a 200 day simple moving average of $81.03. Astera Labs, Inc. has a 52 week low of $36.22 and a 52 week high of $147.39.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.06. The firm had revenue of $113.10 million during the quarter, compared to analysts’ expectations of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The firm’s revenue for the quarter was up 47.1% compared to the same quarter last year. On average, sell-side analysts forecast that Astera Labs, Inc. will post -0.45 earnings per share for the current year.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.